OA12284A - Thiazolidinedione salt for treatment of diabetes mellitus. - Google Patents

Thiazolidinedione salt for treatment of diabetes mellitus. Download PDF

Info

Publication number
OA12284A
OA12284A OA1200200370A OA1200200370A OA12284A OA 12284 A OA12284 A OA 12284A OA 1200200370 A OA1200200370 A OA 1200200370A OA 1200200370 A OA1200200370 A OA 1200200370A OA 12284 A OA12284 A OA 12284A
Authority
OA
OAPI
Prior art keywords
hydrobromide
solvaté
methyl
amino
pyridyl
Prior art date
Application number
OA1200200370A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beechamp P L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beechamp P L C filed Critical Smithkline Beechamp P L C
Publication of OA12284A publication Critical patent/OA12284A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
OA1200200370A 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus. OA12284A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
OA12284A true OA12284A (en) 2003-11-10

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200370A OA12284A (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus.

Country Status (23)

Country Link
EP (1) EP1296980A1 (sk)
JP (1) JP2003535862A (sk)
KR (1) KR20030007918A (sk)
CN (1) CN1443186A (sk)
AP (1) AP2002002673A0 (sk)
AU (1) AU2001264078A1 (sk)
BG (1) BG107357A (sk)
BR (1) BR0111536A (sk)
CA (1) CA2411065A1 (sk)
CZ (1) CZ20023966A3 (sk)
DZ (1) DZ3382A1 (sk)
EA (1) EA200300005A1 (sk)
GB (1) GB0014006D0 (sk)
HU (1) HUP0301137A3 (sk)
IL (1) IL153279A0 (sk)
MA (1) MA25753A1 (sk)
MX (1) MXPA02012100A (sk)
NO (1) NO20025883L (sk)
OA (1) OA12284A (sk)
PL (1) PL360592A1 (sk)
SK (1) SK17142002A3 (sk)
WO (1) WO2001094344A1 (sk)
ZA (1) ZA200209954B (sk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
WO2008091624A2 (en) * 2007-01-22 2008-07-31 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU2001264078A1 (en) 2001-12-17
EP1296980A1 (en) 2003-04-02
CZ20023966A3 (cs) 2003-04-16
AP2002002673A0 (en) 2002-12-31
DZ3382A1 (fr) 2001-12-13
HUP0301137A3 (en) 2005-04-28
EA200300005A1 (ru) 2003-04-24
JP2003535862A (ja) 2003-12-02
BG107357A (bg) 2003-08-29
KR20030007918A (ko) 2003-01-23
NO20025883D0 (no) 2002-12-06
MA25753A1 (fr) 2003-04-01
CA2411065A1 (en) 2001-12-13
GB0014006D0 (en) 2000-08-02
HUP0301137A2 (hu) 2003-08-28
BR0111536A (pt) 2003-07-01
ZA200209954B (en) 2003-10-10
PL360592A1 (en) 2004-09-20
MXPA02012100A (es) 2003-04-25
CN1443186A (zh) 2003-09-17
SK17142002A3 (sk) 2003-10-07
NO20025883L (no) 2003-02-03
WO2001094344A1 (en) 2001-12-13
IL153279A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
OA12284A (en) Thiazolidinedione salt for treatment of diabetes mellitus.
EP1446404B1 (en) Rosiglitazone edisylates and their use as antidiabetics
US20040048899A1 (en) Tartrate salts of thiazollidnedione derivative
EP1305311B1 (en) Tartrate salt of thiazolidinedione derivative
AU2001262550B2 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
EP1325000B1 (en) A thiazolidinedione derivative and its use as antidiabetic
OA12355A (en) Tartrate salts of thiazolidinedione derivative.
US20030162815A1 (en) Thiazolidinedione salt for treatment of diabetes mellitus
EP1448559B1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
AU2001262550A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
US20040087629A1 (en) Tartrate salts of thiazolidinedione derivative
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
WO2003050111A1 (en) Toluenesulfonate salts of a thiazolidinedione derivative
AU2001292034A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AU2005229688A1 (en) Tartrate salts of thiazolidinedione derivative